Sep 09, 2014
1:3
For every 3 shares held, investors received 1. The price per share adjusted from $1.03 to $0.34.
The split itself did not change the total investment value.
Fennec Pharmaceuticals Inc. (FENC) trades on the NASDAQ Capital Market in the Biotechnology industry.
Fennec Pharmaceuticals Inc. company overviewThe latest split shown was on September 9, 2014. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.
This history records 3 reverse splits between August 2, 2005 and September 9, 2014.